313 related articles for article (PubMed ID: 32147582)
1. Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
Langle YV; Balarino NP; Belgorosky D; Cresta Morgado PD; Sandes EO; Marino L; Bilbao ER; Zambrano M; Lodillinsky C; Eiján AM
Nitric Oxide; 2020 May; 98():50-59. PubMed ID: 32147582
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans.
Mitropoulos D; Petsis D; Kyroudi-Voulgari A; Kouloukoussa M; Zervas A; Dimopoulos C
Nitric Oxide; 2005 Aug; 13(1):36-41. PubMed ID: 15964223
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
[TBL] [Abstract][Full Text] [Related]
5. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
[TBL] [Abstract][Full Text] [Related]
6. Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.
Morcos E; Jansson OT; Adolfsson J; Ehrén I; Wiklund NP
J Urol; 2001 Feb; 165(2):678-82. PubMed ID: 11176457
[TBL] [Abstract][Full Text] [Related]
7. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS.
Belgorosky D; Langle Y; Prack Mc Cormick B; Colombo L; Sandes E; Eiján AM
Nitric Oxide; 2014 Jan; 36():11-8. PubMed ID: 24211345
[TBL] [Abstract][Full Text] [Related]
9. iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology.
Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See WA
Urol Oncol; 2014 Jan; 32(1):45.e1-9. PubMed ID: 24054867
[TBL] [Abstract][Full Text] [Related]
10. Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.
Koskela LR; Poljakovic M; Ehrén I; Wiklund NP; de Verdier PJ
Nitric Oxide; 2012 Oct; 27(3):185-91. PubMed ID: 22819699
[TBL] [Abstract][Full Text] [Related]
11. Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.
Yoshino T; Miyazaki J; Kojima T; Kandori S; Shiga M; Kawahara T; Kimura T; Naka T; Kiyohara H; Watanabe M; Yamasaki S; Akaza H; Yano I; Nishiyama H
PLoS One; 2019; 14(1):e0209196. PubMed ID: 30608942
[TBL] [Abstract][Full Text] [Related]
12. Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.
Thiel T; Ryk C; Chatzakos V; Hallén Grufman K; Bavand-Chobot N; Flygare J; Wiklund NP; de Verdier PJ
Cancer Lett; 2014 Jun; 348(1-2):119-25. PubMed ID: 24657658
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model.
Lodillinsky C; Langle Y; Guionet A; Góngora A; Baldi A; Sandes EO; Casabé A; Eiján AM
PLoS One; 2010 Oct; 5(10):e13571. PubMed ID: 21042580
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.
Prack Mc Cormick B; Belgorosky D; Langle Y; Balarino N; Sandes E; Eiján AM
Nitric Oxide; 2017 Apr; 64():22-30. PubMed ID: 28126499
[TBL] [Abstract][Full Text] [Related]
15. Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways.
Girouard J; Belgorosky D; Hamelin-Morrissette J; Boulanger V; D'Orio E; Ramla D; Perron R; Charpentier L; Van Themsche C; Eiján AM; Bérubé G; Reyes-Moreno C
Biochem Pharmacol; 2020 Jun; 176():113778. PubMed ID: 31877271
[TBL] [Abstract][Full Text] [Related]
16. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.
Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P
Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
Jpn J Cancer Res; 2000 May; 91(5):534-42. PubMed ID: 10835499
[TBL] [Abstract][Full Text] [Related]
18. Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer.
Hosseini A; Koskela LR; Ehrén I; Aguilar-Santelises M; Sirsjö A; Wiklund NP
Nitric Oxide; 2006 Dec; 15(4):337-43. PubMed ID: 16517187
[TBL] [Abstract][Full Text] [Related]
19. Contributors to HMGB1 release by urothelial carcinoma cells in response to bacillus Calmette-Guérin.
Zhang G; Chen F; Cao Y; See WA
J Urol; 2013 Oct; 190(4):1398-403. PubMed ID: 23583857
[TBL] [Abstract][Full Text] [Related]
20. Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
Atallah A; Grossman A; Nauman RW; Paré JF; Khan A; Siemens DR; Cotechini T; Graham CH
Int J Cancer; 2024 Jul; 155(2):352-364. PubMed ID: 38483404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
